Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

307 Articles

Jon C. Ogg | Sep 23, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart, Yum Brands and More

The top analyst upgrades, downgrades and initiations seen on Friday morning include Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart and…

Chris Lange | Sep 13, 2016 at 7:05 AM EDT

Short Sellers Run for Cover From Major Biotechs

The August 31 short interest data have been compared with the previous report, and short interest decreased for most of…

Chris Lange | Aug 25, 2016 at 8:40 AM EDT

Short Sellers Increase Bets in Major Biotechs

The August 15 short interest data have been compared with the previous report, and short interest moves were mixed across…

Chris Lange | Aug 10, 2016 at 8:50 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the July 29 settlement date and short interest decreased across these selected biotech…

Chris Lange | Jul 27, 2016 at 7:50 AM EDT

Major Biotechs See Increased Short Interest Bets

The short interest data are out for the July 15 settlement date. Short interest increased across many of these selected…

Chris Lange | Jul 13, 2016 at 8:10 AM EDT

Short Sellers Become More Selective on Major Biotechs

The June 30 short interest data have been compared with the previous report, and short interest moves were mixed in…

Chris Lange | Jul 12, 2016 at 10:10 AM EDT

Biotechs With Drug Pipelines Closest to Zero Valuation

Credit Suisse has taken a look at which biotech companies in its coverage have the least credit given to pipeline…

Jon C. Ogg | Jun 27, 2016 at 8:44 AM EDT

Top Analyst Upgrades and Downgrades: Alexion, Barrick Gold, Barclays, Coeur Mining, GW Pharma, SE, AGCO, HSBC, RBS and Many More

Things might have felt bad on Friday’s post-Brexit surprise, but the Dow’s drop of 610 points, a drop of 3.4%,…

Chris Lange | Jun 27, 2016 at 7:55 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the June 15 settlement date. Biotech companies are considered a riskier group of…

Paul Ausick | Jun 22, 2016 at 4:04 PM EDT

Verifone, Biogen Crash Wednesday’s 52-Week Low Club

June 22, 2016: Here are four stocks trading with relatively heavy volume among 40 equities making new 52-week lows in…

Chris Lange | Jun 10, 2016 at 8:10 AM EDT

Short Sellers Become More Selective on Major Biotechs

The May 31 short interest data have been compared with the previous report, and short interest moves were mixed in…

Chris Lange | May 25, 2016 at 8:20 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The May 13 short interest data have been compared with the previous report, and short interest moves were mixed in…

Chris Lange | May 11, 2016 at 8:15 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the April 29 settlement date, and short interest moves were mixed in these…

Chris Lange | May 1, 2016 at 10:50 AM EDT

Analysts Make Major Changes to Top Biotech Ratings

With earnings having just been released for some of the top biotech companies, we saw a flurry of analyst calls…

Jon C. Ogg | Apr 29, 2016 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Amazon, Ford, Gilead, Level 3, Sarepta, Western Digital, Whiting Petroleum and More

The top analyst upgrades, downgrades and initiations seen on Friday morning include Amazon, Ford, Gilead, Level 3, Sarepta, Western Digital…

1 … 11 12 13 14 15 … 21

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

Top Analyst Upgrades and Downgrades: Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart, Yum Brands and More

Short Sellers Run for Cover From Major Biotechs

Short Sellers Increase Bets in Major Biotechs

Short Sellers Run for Cover From Major Biotechs

Major Biotechs See Increased Short Interest Bets

Short Sellers Become More Selective on Major Biotechs

Biotechs With Drug Pipelines Closest to Zero Valuation

Top Analyst Upgrades and Downgrades: Alexion, Barrick Gold, Barclays, Coeur Mining, GW Pharma, SE, AGCO, HSBC, RBS and Many More

Short Sellers Run for Cover From Major Biotechs

Verifone, Biogen Crash Wednesday’s 52-Week Low Club

Short Sellers Become More Selective on Major Biotechs

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Run for Cover From Major Biotechs

Analysts Make Major Changes to Top Biotech Ratings

Top Analyst Upgrades and Downgrades: Amazon, Ford, Gilead, Level 3, Sarepta, Western Digital, Whiting Petroleum and More

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

Top Analyst Upgrades and Downgrades: Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart, Yum Brands and More

Short Sellers Run for Cover From Major Biotechs

Short Sellers Increase Bets in Major Biotechs

Short Sellers Run for Cover From Major Biotechs

Major Biotechs See Increased Short Interest Bets

Short Sellers Become More Selective on Major Biotechs

Biotechs With Drug Pipelines Closest to Zero Valuation

Top Analyst Upgrades and Downgrades: Alexion, Barrick Gold, Barclays, Coeur Mining, GW Pharma, SE, AGCO, HSBC, RBS and Many More

Short Sellers Run for Cover From Major Biotechs

Verifone, Biogen Crash Wednesday’s 52-Week Low Club

Short Sellers Become More Selective on Major Biotechs

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Run for Cover From Major Biotechs

Analysts Make Major Changes to Top Biotech Ratings

Top Analyst Upgrades and Downgrades: Amazon, Ford, Gilead, Level 3, Sarepta, Western Digital, Whiting Petroleum and More

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do